Cargando…

Adherence and Effects Derived from FODMAP Diet on Irritable Bowel Syndrome: A Real Life Evaluation of a Large Follow-Up Observation

Introduction: Irritable bowel syndrome represents one of the most difficult gastroenterological diseases to treat, that usually induces the patients to follow different drug therapies, often not useful in symptom control. In this scenario low FODMAP diet could have positive effects in patients with...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gravina, Antonietta Gerarda, Dallio, Marcello, Romeo, Mario, Di Somma, Antonietta, Cotticelli, Gaetano, Loguercio, Carmelina, Federico, Alessandro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7231245/ https://www.ncbi.nlm.nih.gov/pubmed/32230832 http://dx.doi.org/10.3390/nu12040928

Ejemplares similares

Vascular Endothelial Dysfunction in Inflammatory Bowel Diseases: Pharmacological and Nonpharmacological Targets
por: Gravina, Antonietta Gerarda, et al.
Publicado: (2018)

Skin Adverse Events During Dual and Triple Therapy for HCV-Related Cirrhosis
por: Federico, Alessandro, et al.
Publicado: (2014)

Nutrigenomics and Nutrigenetics in Metabolic- (Dysfunction) Associated Fatty Liver Disease: Novel Insights and Future Perspectives
por: Dallio, Marcello, et al.
Publicado: (2021)

Role of Oxidative Stress in Pathophysiology of Nonalcoholic Fatty Liver Disease
por: Masarone, Mario, et al.
Publicado: (2018)

Corrigendum to “Role of Oxidative Stress in Pathophysiology of Nonalcoholic Fatty Liver Disease”
por: Masarone, Mario, et al.
Publicado: (2021)

Carcinogenesis as a Result of Multiple Inflammatory and Oxidative Hits: a Comprehensive Review from Tumor Microenvironment to Gut Microbiota
por: Morgillo, Floriana, et al.
Publicado: (2018)

Safety and efficacy of sorafenib in patients with advanced hepatocellular carcinoma and Child-Pugh A or B cirrhosis
por: FEDERICO, ALESSANDRO, et al.
Publicado: (2015)

Just Drink a Glass of Water? Effects of Bicarbonate–Sulfate–Calcium–Magnesium Water on the Gut–Liver Axis
por: Gravina, Antonietta Gerarda, et al.
Publicado: (2022)

The Bisphenol A Induced Oxidative Stress in Non-Alcoholic Fatty Liver Disease Male Patients: A Clinical Strategy to Antagonize the Progression of the Disease
por: Federico, Alessandro, et al.
Publicado: (2020)

Qualitative and Quantitative Evaluation of Dietary Intake in Patients with Non-Alcoholic Steatohepatitis
por: Federico, Alessandro, et al.
Publicado: (2017)

Evaluation of the Effect Derived from Silybin with Vitamin D and Vitamin E Administration on Clinical, Metabolic, Endothelial Dysfunction, Oxidative Stress Parameters, and Serological Worsening Markers in Nonalcoholic Fatty Liver Disease Patients
por: Federico, Alessandro, et al.
Publicado: (2019)

Coeliac disease and C virus-related chronic hepatitis: a non association
por: Gravina, Antonietta Gerarda, et al.
Publicado: (2012)

Is low FODMAP diet effective in children with irritable bowel syndrome?
por: Dogan, Guzide, et al.
Publicado: (2020)

Chemical Effect of Bisphenol A on Non-Alcoholic Fatty Liver Disease
por: Dallio, Marcello, et al.
Publicado: (2019)

Silymarin/Silybin and Chronic Liver Disease: A Marriage of Many Years
por: Federico, Alessandro, et al.
Publicado: (2017)

Commentary: Adherence with a low-FODMAP diet in irritable bowel syndrome: are eating disorders the missing link?
por: Chumpitazi, Bruno P., et al.
Publicado: (2019)

Low-FODMAP Diet for the Management of Irritable Bowel Syndrome in Remission of IBD
por: Więcek, Martyna, et al.
Publicado: (2022)

The Melanocortin System in Inflammatory Bowel Diseases: Insights into Its Mechanisms and Therapeutic Potentials
por: Gravina, Antonietta Gerarda, et al.
Publicado: (2023)

Low-FODMAP diet reduces irritable bowel symptoms in patients with inflammatory bowel disease
por: Pedersen, Natalia, et al.
Publicado: (2017)

Evaluation of the Efficacy and Safety of a Compound of Micronized Flavonoids in Combination With Vitamin C and Extracts of Centella asiatica, Vaccinium myrtillus, and Vitis vinifera for the Reduction of Hemorrhoidal Symptoms in Patients With Grade II and III Hemorrhoidal Disease: A Retrospective Real-Life Study
por: Gravina, Antonietta G., et al.
Publicado: (2021)

Efficacy of the low FODMAP diet for treating irritable bowel syndrome: the evidence to date
por: Nanayakkara, Wathsala S, et al.
Publicado: (2016)

Therapeutic adherence recorded in the outpatient follow-up of inflammatory bowel diseases in a referral center: Damages of COVID-19()
por: Pellegrino, Raffaele, et al.
Publicado: (2022)

A 60-Year-Old Woman with Primary Biliary Cholangitis and Crohn’s Ileitis Following the Suspension of Ursodeoxycholic Acid
por: Romeo, Mario, et al.
Publicado: (2022)

Helicobacter pylori and extragastric diseases: A review
por: Gravina, Antonietta Gerarda, et al.
Publicado: (2018)

Low-FODMAP Diet Improves Irritable Bowel Syndrome Symptoms: A Meta-Analysis
por: Altobelli, Emma, et al.
Publicado: (2017)

Early experience with a low FODMAP diet in Asian patients with irritable bowel syndrome
por: Wong, Zhiqin, et al.
Publicado: (2018)

Secondary Extramedullary Plasmacytoma of the Duodenum: An Unusual Endoscopic Presentation
por: Gravina, Antonietta Gerarda, et al.
Publicado: (2013)

Regorafenib in combination with silybin as a novel potential strategy for the treatment of metastatic colorectal cancer
por: Belli, Valentina, et al.
Publicado: (2017)

Immunity as Cornerstone of Non-Alcoholic Fatty Liver Disease: The Contribution of Oxidative Stress in the Disease Progression
por: Dallio, Marcello, et al.
Publicado: (2021)

Diet and Non-Alcoholic Fatty Liver Disease: The Mediterranean Way
por: Abenavoli, Ludovico, et al.
Publicado: (2019)

Glutamine Supplementation Enhances the Effects of a Low FODMAP Diet in Irritable Bowel Syndrome Management
por: Rastgoo, Samira, et al.
Publicado: (2021)

Two microbiota subtypes identified in irritable bowel syndrome with distinct responses to the low FODMAP diet
por: Vervier, Kevin, et al.
Publicado: (2022)

PNPLA3, TM6SF2, and MBOAT7 Influence on Nutraceutical Therapy Response for Non-alcoholic Fatty Liver Disease: A Randomized Controlled Trial
por: Dallio, Marcello, et al.
Publicado: (2021)

Low FODMAP Diet and Probiotics in Irritable Bowel Syndrome: A Systematic Review With Network Meta-analysis
por: Xie, Chao-Rong, et al.
Publicado: (2022)

The Usefulness of the Low-FODMAP Diet with Limited Tryptophan Intake in the Treatment of Diarrhea-Predominant Irritable Bowel Syndrome
por: Chojnacki, Cezary, et al.
Publicado: (2023)

Editorial: Challenges in Inflammatory Bowel Disease: Current, Future and Unmet Needs
por: Gravina, Antonietta Gerarda, et al.
Publicado: (2022)

Editorial: Challenges in inflammatory bowel disease: current, future and unmet needs, volume II
por: Gravina, Antonietta Gerarda, et al.
Publicado: (2023)

Long-term irritable bowel syndrome symptom control with reintroduction of selected FODMAPs
por: Harvie, Ruth M, et al.
Publicado: (2017)

Efficacy of a low-FODMAP diet in adult irritable bowel syndrome: a systematic review and meta-analysis
por: van Lanen, Anne-Sophie, et al.
Publicado: (2021)

Effect of Low FODMAPs Diet on Irritable Bowel Syndromes: A Systematic Review and Meta-Analysis of Clinical Trials
por: Hahn, Jongsung, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ch8q1m98769dvcca3a060igki8